Hallucinating mice, dopamine and immunity; towards mechanistic treatment targets for psychosis
Psychiatry, Behavioral Neuroscience, Neuroscience and seminar by Dr. Katharina Schmack, Francis Crick Institute, London
Hosted by TINS Neurotwin
Thursday 15:00–16:10 London (GMT+0)
Ended
Abstract
Hallucinations are a core symptom of psychotic disorders and have traditionally been difficult to study biologically. We developed a new behavioral computational approach to measure hallucinations-like perception in humans and mice alike. Using targeted neural circuit manipulations, we identified a causal role for striatal dopamine in mediating hallucination-like perception. Building on this, we currently investigate the neural and immunological upstream regulators of these dopaminergic circuits with the goal to identify new biological treatment targets for psychosis
Topics
Related seminars
- Video · 55 min · Apr 8, 2022Greg Schwartz, Northwestern University
Psychedelics and the Pharmacology of Consciousness
Video · 57 min · Apr 15, 2021Olivia Carter, The university of Melbourne
More from TINS Neurotwin
All talksStability of visual processing in passive and active vision
Mar 28, 2024Tobias RosePredictive processing: a circuit approach to psychosis
Video · 1 h 8 min · Mar 14, 2024Georg KellerThe balanced brain: two-photon microscopy of inhibitory synapse formation
May 11, 2023Corette WierengaZebrafish models help untangle genetic interactions in motor neuron degeneration
May 31, 2022Sorana Ciura
More with Katharina Schmack
All their workHallucinating mice and dopamine – towards mechanistic treatment targets for psychosis
Seminar · Apr 28, 2021Transatlantic Systems Neuro